Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-17-050277

Options or other derivatives

  • Chief Financial Officer acquired 132,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Golubieski John Chief Financial Officer 2017-08-04 Grant or award · Employee Stock Option (Right to Buy) +132,000 132,000 D
Loading xslF345X03/a4.xml…